4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-24-004630
EVP R&D, Chief Medical Officer gave up 15,280 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 46,658 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2024-02-08 | Grant or award | +46,658 | 103,217 | D: show line 1 in the form | ||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2024-02-08 | Shares withheld for taxes | −15,280 | $26.77 | $409,046 | 87,937 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2023-11-17 | Other acquisition · Employee Stock Option (Right to Buy) | +1,599 | $58.40 | $93,382 | 81,599 | D: show line 3 in the form | |||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2023-11-17 | Other acquisition · Employee Stock Option (Right to Buy) | +1,089 | $65.94 | $71,809 | 55,589 | D: show line 4 in the form | |||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2023-11-17 | Other acquisition · Employee Stock Option (Right to Buy) | +2,133 | $31.93 | $68,107 | 108,833 | D: show line 5 in the form | |||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2023-11-17 | Other acquisition · Employee Stock Option (Right to Buy) | +3,376 | $20.03 | $67,621 | 172,232 | D: show line 6 in the form | |||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2023-11-17 | Other acquisition · Restricted Stock Unit Award | +201 | 10,297 | D: show line 7 in the form | |||||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2023-11-17 | Other acquisition · Employee Stock Option (Right to Buy) | +3,929 | $19.34 | $75,987 | 200,413 | D: show line 8 in the form | |||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2023-11-17 | Other acquisition · Restricted Stock Unit Award | +481 | 24,557 | D: show line 9 in the form | |||||
| Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2023-11-17 | Other acquisition · Employee Stock Option (Right to Buy) | +2,790 | $24.59 | $68,606 | 142,344 | D: show line 10 in the form |
Loading xslF345X05/form4.xml…